Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition A | ASCA | Apr 18, 2024 | 3.01 | 0.00 |
A SPAC I Acquisition Unit | ASCAU | Apr 18, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Apr 18, 2024 | 11.08 | 0.00 |
A-Mark Precious Metals | AMRK | Apr 18, 2024 | 36.88 | +0.33 |
a.k.a Brands | AKA | Apr 18, 2024 | 11.56 | 0.00 |
A.O Smith | AOS | Apr 18, 2024 | 86.69 | +0.27 |
A10 Networks | ATEN | Apr 18, 2024 | 12.85 | +0.39 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 18, 2024 | 46.06 | -0.22 |
Aadi Bioscience | AADI | Apr 18, 2024 | 1.80 | -1.10 |
AAON | AAON | Apr 18, 2024 | 85.24 | -1.23 |
AAR | AIR | Apr 18, 2024 | 63.03 | +1.87 |
Abacus Life | ABL | Apr 18, 2024 | 11.84 | +0.42 |
Abbott Laboratories | ABT | Apr 18, 2024 | 105.27 | -0.59 |
AbbVie | ABBV | Apr 18, 2024 | 164.66 | +0.25 |
AbCellera Biologics | ABCL | Apr 18, 2024 | 3.91 | -0.26 |
Abeona Therapeutics | ABEO | Apr 18, 2024 | 7.53 | -5.04 |
Abercrombie & Fitch | ANF | Apr 18, 2024 | 109.32 | -3.67 |
Aberdeen Asia-Pacificome Fund | FAX | Apr 18, 2024 | 2.60 | +0.39 |
Aberdeen Australia Equity Fund | IAF | Apr 18, 2024 | 4.17 | -0.48 |
Aberdeen Emerging Markets Fund | AEF | Apr 18, 2024 | 4.87 | -0.41 |
Aberdeen Global Fund | FCO | Apr 18, 2024 | 5.50 | 0.00 |
Aberdeen Global Infrastructure | ASGI | Apr 18, 2024 | 16.74 | 0.00 |
Aberdeen Income Credit Strategies Fund | ACP | Apr 18, 2024 | 6.72 | +0.75 |
Aberdeen Income Credit Strategies Pref | ACP-A | Apr 18, 2024 | 23.44 | +1.00 |
Aberdeen Japan Equity Fund | JEQ | Apr 18, 2024 | 5.81 | 0.00 |
Abits Group | ABTS | Apr 18, 2024 | 0.76 | +3.98 |
Abivax SA - American Depositary Shares | ABVX | Apr 18, 2024 | 15.11 | +1.55 |
Able View Global | ABLV | Apr 18, 2024 | 1.69 | -2.32 |
ABM Industries | ABM | Apr 18, 2024 | 43.80 | +0.37 |
Abrdn Global Dynamic Dividend Fund | AGD | Apr 18, 2024 | 9.17 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.